Incidence of cervical intraepithelial neoplasia in Estonia.
作者： Anneli Uusküla , Mait Raag , Arno Uppin , Terje Raud , Ursula Klaar
DOI: 10.1097/LGT.0B013E3182652213
关键词:
摘要: OBJECTIVE This study aimed to assess the incidence of cervical intraepithelial neoplasia (CIN) by grade (CIN 1, CIN 2, 3) and age in Estonia (a country with less developed cancer screening program high incidence). MATERIALS AND METHODS descriptive uses data from a health insurance fund covering whole estimate grade. case definition was based on specific diagnostic procedures (biopsy, pathological diagnosis, colposcopy) and/or treatment (excision, local destructive therapy, conization, hysterectomy) CIN-specific diagnosis code (International Statistical Classification Diseases, 10 Revision) reported care claims. Age-specific rates were calculated together 95% CIs. Main outcome measure includes grade-specific rate per 1,000 women. RESULTS The estimates for women range 0.68 2.83 0.63 1.24 0.13 0.53 3 narrow (biopsy/pathological based) broad (any procedure/treatment criteria, respectively. CONCLUSIONS Our dysplasia disease frequency distribution are line those other countries. Administrative resources (such as data) valuable source research.
wkhealth.com参考文章(25)
Paolo Giorgi Rossi, Alessandro Ricciardi, Catherine Cohet, Fabio Palazzo, Giacomo Furnari, Sabrina Valle, Nathalie Largeron, Antonio Federici, Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy BMC Public Health. ,vol. 9, pp. 71- 71 ,(2009) , 10.1186/1471-2458-9-71
L.Stewart Massad, Yvonne C. Collins, Peter M. Meyer, Biopsy Correlates of Abnormal Cervical Cytology Classified Using the Bethesda System Gynecologic Oncology. ,vol. 82, pp. 516- 522 ,(2001) , 10.1006/GYNO.2001.6323
W. Prendiville, J. Jordan, P. Martin-Hirsch, M. Arbyn, U. Schenck, J.-J. Baldauf, D. Da Silva, A. Anttila, P. Nieminen, European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology. ,vol. 20, pp. 5- 16 ,(2009) , 10.1111/J.1365-2303.2008.00636.X
Maarit Leinonen, Laura Kotaniemi‐Talonen, Ahti Anttila, Tadeusz Dyba, Jussi Tarkkanen, Pekka Nieminen, Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. International Journal of Cancer. ,vol. 123, pp. 1344- 1349 ,(2008) , 10.1002/IJC.23670
Henry J. Henk, Ralph P. Insinga, Puneet K. Singhal, Theodore Darkow, Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population. Journal of Lower Genital Tract Disease. ,vol. 14, pp. 29- 36 ,(2010) , 10.1097/LGT.0B013E3181AC05E9
Anneli Uusküla, Mart Kals, Liina Kosenkranius, Louise-Anne McNutt, Jack DeHovitz J, Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infectious Diseases. ,vol. 10, pp. 63- 63 ,(2010) , 10.1186/1471-2334-10-63
J. Jordan, M. Arbyn, P. Martin-Hirsch, U. Schenck, J-J. Baldauf, D. Da Silva, A. Anttila, P. Nieminen, W. Prendiville, European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology. ,vol. 19, pp. 342- 354 ,(2008) , 10.1111/J.1365-2303.2008.00623.X
George F Sawaya, Karla Kerlikowske, Nancy C Lee, Ginny Gildengorin, A Eugene Washington, Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstetrics & Gynecology. ,vol. 96, pp. 219- 223 ,(2000) , 10.1016/S0029-7844(00)00882-6
Terry S. Dunn, Mary Burke, James Shwayder, A “See and Treat” Management for High-Grade Squamous Intraepithelial Lesion Pap Smears Journal of Lower Genital Tract Disease. ,vol. 7, pp. 104- 106 ,(2003) , 10.1097/00128360-200304000-00006
Jorma Paavonen, Human papillomavirus infection and the development of cervical cancer and related genital neoplasias International Journal of Infectious Diseases. ,vol. 11, ,(2007) , 10.1016/S1201-9712(07)60015-0